The safety and efficacy of BEPREVE® have not been established in pediatric patients under 3 years of age
Efficacy of BEPREVE® in pediatric patients with age < 10 was extrapolated from clinical trials conducted in pediatric patients with age >10 and in adults
Relevant warnings and precautions:
For topical ophthalmic use only
Do not touch the eyelids or surrounding areas with the dropper tip of the bottle and keep bottle tightly closed when not in use
Do not use to treat contact lens-related irritation
Do not instill while wearing contact lenses. Lenses may be reinserted after 10 minutes following administration.
Should not be used in pregnant women unless the benefit to the mother justifies the potential risk to the fetus
PrBEPREVE® (bepotastine besilate ophthalmic solution) 1.5% w/v is indicated for the treatment of itching associated with allergic conjunctivitis
The safety and efficacy of BEPREVE® have not been established in pediatric patients under 3 years of age
Efficacy of BEPREVE® in pediatric patients with age < 10 was extrapolated from clinical trials conducted in pediatric patients with age >10 and in adults
Relevant warnings and precautions:
For topical ophthalmic use only
Do not touch the eyelids or surrounding areas with the dropper tip of the bottle and keep bottle tightly closed when not in use
Do not use to treat contact lens-related irritation
Do not instill while wearing contact lenses. Lenses may be reinserted after 10 minutes following administration
Should not be used in pregnant women unless the benefit to the mother justifies the potential risk to the fetus
